Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generation Bio

generationbio.com

Latest From Generation Bio

Start-Up Quarterly Statistics: Financings Finally Rise In Q1, But Deals Stagnate

Biopharma start-ups finally had an increase in financing activity, following three sequential quarters with a decrease. A review of biopharma start-up dealmaking and financing activity from January through March 2018, based on data from Strategic Transactions.

Deals Financing

Finance Watch: VC Interest Lags At Early Stage – 'Hogwash' Or Evidence-Based?

Venture Capital Edition: A VC investor at a recent conference said it's "hogwash" that venture capitalists aren't interested in funding early-stage biopharma, but the trend toward large financings – such as the $220m raised to date by Rubius – and 2017 investment data suggest otherwise.

Financing Business Strategies

Venture Funding Deals: Celularity Launches With $250m; Generation Bio Grabs $100m Series B

Celularity launched with $250m to develop cell therapies with technology licensed from Celgene and others, while mRNA specialist Moderna brought in another $500m mega round and Generation Bio closed a $100m Series B to fund ongoing gene therapy programs.
Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Hepatic (Liver)
  • Metabolic Disorders
  • Neurology, Nervous System
  • Ophthalmic
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Generation Bio
  • Senior Management
  • Geoff McDonough, MD, President & CEO
    Glenn Goodard, CFO
    Mark Angelino, PhD, Founder & COO
    Doug Kerr, MD, PhD, Head of R&D
    Rob Kotin, PhD, Founder & Head of Discovery
    Geary Macquiddy, Senior Director, Program Management
    Phillip Samayoa, PhD, Senior Director, Strategy & Portfolio Dev
    Matt Stanton, PhD, Head, Platform Research
    Jennifer Elliott, PhD, JD, VP, Head of Legal and IP
    Will McCarthy, CBO
  • Contact Info
  • Generation Bio
    215 First Street
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register